5ROU
PanDDA analysis group deposition -- Proteinase K crystal structure Apo72
5ROU の概要
エントリーDOI | 10.2210/pdb5rou/pdb |
Group deposition | PanDDA analysis of Frag Xtal Screen vs. PrtK (G_1002169) |
分子名称 | Proteinase K, SULFATE ION (3 entities in total) |
機能のキーワード | fragmax, fragmaxapp, fragment screening, hydrolase, inhibition |
由来する生物種 | Parengyodontium album |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 29054.85 |
構造登録者 | Lima, G.M.A.,Talibov, V.,Benz, L.S.,Jagudin, E.,Mueller, U. (登録日: 2020-09-23, 公開日: 2021-05-26, 最終更新日: 2021-06-23) |
主引用文献 | Lima, G.M.A.,Jagudin, E.,Talibov, V.O.,Benz, L.S.,Marullo, C.,Barthel, T.,Wollenhaupt, J.,Weiss, M.S.,Mueller, U. FragMAXapp: crystallographic fragment-screening data-analysis and project-management system. Acta Crystallogr D Struct Biol, 77:799-808, 2021 Cited by PubMed Abstract: Crystallographic fragment screening (CFS) has become one of the major techniques for screening compounds in the early stages of drug-discovery projects. Following the advances in automation and throughput at modern macromolecular crystallography beamlines, the bottleneck for CFS has shifted from collecting data to organizing and handling the analysis of such projects. The complexity that emerges from the use of multiple methods for processing and refinement and to search for ligands requires an equally sophisticated solution to summarize the output, allowing researchers to focus on the scientific questions instead of on software technicalities. FragMAXapp is the fragment-screening project-management tool designed to handle CFS projects at MAX IV Laboratory. It benefits from the powerful computing infrastructure of large-scale facilities and, as a web application, it is accessible from everywhere. PubMed: 34076593DOI: 10.1107/S2059798321003818 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.06 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード